PAL-200

N/A

Report date: 2026/01/04 17:56:08

Base Information

Drug NamePAL-200
Drug Alias NameRecombinant endolysin (iNtRON Biotechnology)PAL-200
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPropionibacterium acnes infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntron Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntron Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsPropionibacterium acnes infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A